Device Trial Radar · NCT04184011
Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars
Last checked: Nov 20, 2026Latest source record: Dec 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Aug 15, 2019
Primary completion
Aug 16, 2020
Study completion Aug 16, 2020
Sponsor
- Lead sponsor
- Sensus HealthcareNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 3, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Keloid formation in response to skin trauma inflicts about 18 million individuals. A key impediment in successful treatment of keloids is that the predominant treatments, particularly surgical excision and shaving, tend to initiate the regrowth of the keloid at the excision site, and therefore, recurrence rates are high. There is much evidence to demonstrate that following surgical excision procedures with a course of radiation therapy can significantly reduce recurrence rates to as little as 10% or below. This prospective study is to evaluate this claim.
Conditions
- Keloid Scar
Interventions
SRT-100™Device
SRT delivers a precise, calibrated dose of radiotherapy following surgical excision for large and more difficult-to-treat keloids that cannot otherwise be treated by or have failed more conservative measures.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of keloid recurrence rates.Time frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dermatology and Dermatological Surgery
Boynton Beach, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.